PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, New Jersey 07080, United States.
Org Lett. 2013 Apr 19;15(8):1882-5. doi: 10.1021/ol4005382. Epub 2013 Apr 10.
Strategies for carrying out the reaction of 4,6-dichloropyrimidine-5-carboxaldehyde with various hydrazines to generate 1-substituted 4-chloropyrazolo[3,4-d]pyrimidines in a selective and high-yielding manner are presented. For aromatic hydrazines, the reaction is performed in the absence of an external base, which promotes exclusive hydrazone formation. The hydrazones subsequently cyclize at an elevated temperature to form the desired pyrazolo[3,4-d]pyrimidine products. For aliphatic hydrazines, the reaction sequence proceeds as a single step in the presence of an external base.
介绍了以选择性和高产率的方式进行 4,6-二氯嘧啶-5-甲醛与各种肼的反应,生成 1-取代的 4-氯吡唑并[3,4-d]嘧啶的策略。对于芳族肼,反应在没有外部碱的情况下进行,这促进了肼的形成。随后,腙在高温下环化形成所需的吡唑并[3,4-d]嘧啶产物。对于脂肪族肼,反应序列在外源碱的存在下以单步进行。